3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3063B |
Mycophenolic Acid and Metabolite, Blood |
3063SP |
Mycophenolic Acid and Metabolite, Serum/Plasma |
3063U |
Mycophenolic Acid and Metabolite, Urine |
3092SP |
Moricizine, Serum/Plasma |
3111B |
Naloxone - Free (Unconjugated), Blood |
3111SP |
Naloxone - Free (Unconjugated), Serum/Plasma |
3111U |
Naloxone - Total (Conjugated/Unconjugated), Urine |
3113U |
Naloxone - Total (Conjugated/Unconjugated) Screen, Urine |
3116B |
Naltrexone and Metabolite - Free (Unconjugated), Blood |
3116SP |
Naltrexone and Metabolite - Free (Unconjugated), Serum/Plasma |
3116U |
Naltrexone and Metabolite - Total (Conjugated/Unconjugated), Urine |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |